CytomX Therapeutics, Inc. (28) | Human Resources (17)

Browse by Subcategory

Recent Contracts

Retirement Agreement by and between CytomX Therapeutics, Inc and Dr. W. Michael Kavanaugh, dated as of December 1, 2020 (Filed With SEC on February 24, 2021)
Consulting Agreement effective as of December 14, 2020, by and between CytomX Therapeutics, Inc and Dr. W. Michael Kavanaugh (Filed With SEC on February 24, 2021)
Employment Offer Letter Agreement between CytomX Therapeutics, Inc. and Carlos Campoy dated as of March 9, 2020 (Filed With SEC on May 7, 2020)
Severance and Change of Control Agreement dated March 23, 2020, by and between CytomX Therapeutics, Inc. and Carlos Campoy (Filed With SEC on May 7, 2020)
Separation Agreement effective as of September 5, 2019, by and between CytomX Therapeutics, Inc. and Rachel W. Humphrey, M.D (Filed With SEC on November 7, 2019)
2019 Employment Inducement Incentive Plan adopted on September 18, 2019 (2019 Plan) (Filed With SEC on November 7, 2019)
Severance and Change of Control Agreement effective as of February 3, 2020, by and between CytomX Therapeutics, Inc. and Alison Hannah, M.D (Filed With SEC on February 27, 2020)
Severance and Change of Control Agreement effective as of October 14, 2019, by and between CytomX Therapeutics, Inc. and Amy C. Peterson, M.D (Filed With SEC on November 7, 2019)
Employment Offer Letter Agreement between CytomX Therapeutics, Inc. and Amy C. Peterson, M.D. dated as of September 23, 2019 (Filed With SEC on November 7, 2019)
Consulting Agreement effective as of August 19, 2019, by and between CytomX Therapeutics, Inc. and Rachel W. Humphrey, M.D (Filed With SEC on November 7, 2019)
Amended and Restated Severance and Change of Control Agreement dated February 27, 2019, by and between CytomX Therapeutics, Inc. and Sean McCarthy. D. Phil (Filed With SEC on May 9, 2019)
Consulting Agreement effective as of May 15, 2019, by and between CytomX Therapeutics, Inc. and Debanjan Ray (Filed With SEC on May 9, 2019)
Amended and Restated Severance and Change of Control Agreement dated March 25, 2019, by and between CytomX Therapeutics, Inc. and Debanjan Ray (Filed With SEC on May 9, 2019)
Amended and Restated Severance and Change of Control Agreement dated March 25, 2019, by and between CytomX Therapeutics, Inc. and Michael Kavanaugh, M.D (Filed With SEC on May 9, 2019)
Amended and Restated Severance and Change of Control Agreement dated March 25, 2019, by and between CytomX Therapeutics, Inc. and Rachel W. Humphrey, M.D (Filed With SEC on May 9, 2019)
Amended and Restated Severance and Change of Control Agreement dated March 25, 2019, by and between CytomX Therapeutics, Inc. and Lloyd Rowland (Filed With SEC on May 9, 2019)
Consulting Agreement between CytomX Therapeutics, Inc and Dr. Hoyoung Huh, effective as of December 30, 2018 (Filed With SEC on February 27, 2019)